The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
The conclave brought together over 1,000 delegates from across India and internationally
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
India continues to face a major maternal nutrition challenge, with nearly 60% of women affected by anaemia and more than 70% experiencing calcium deficiency
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
This makes VLCC the sole institution in the country authorised to conduct in-person NCLC exams
Subscribe To Our Newsletter & Stay Updated
